Heidi S. Wirtz, PharmD, PhD

Articles by Heidi S. Wirtz, PharmD, PhD

Health Care Resource Utilization, Quality Metrics, and Costs of Bladder Cancer Within the Oncology Care Model

ByHeidi S. Wirtz, PharmD, PhD,Zsolt Hepp, PharmD, MSc,Simrun Grewal, PhD,Phoebe Wright, PharmD, MSc,Rupali Fuldeore, MSc,Samantha Tomicki, MPH,Jared Hirsch, MSc,Gabriela Dieguez, MSc,L. Johnetta Blakely, MD

March 16th 2023

Spending on novel therapies in high-risk bladder cancer had minimal impact on Oncology Care Model payments to practices, according to this cohort study and an average performance estimation.

Latest Updated Articles

Health Care Resource Utilization, Quality Metrics, and Costs of Bladder Cancer Within the Oncology Care Model
Published: March 16th 2023 | Updated:

Heidi S. Wirtz, PharmD, PhD

Articles by Heidi S. Wirtz, PharmD, PhD

Health Care Resource Utilization, Quality Metrics, and Costs of Bladder Cancer Within the Oncology Care Model

Latest Updated Articles

Trending on AJMC

FDA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis

Pulling Back Funding for Research COuld Leave HIV Treatment in Worse State: Patrick Sullivan, DVM, PhD

Value-Based Care Interventions and Management of CKD Progression

HMA Combination Therapy Boosts Survival in Accelerated- or Blast-Phase MPNs

NICU Nurses More Likely to Miss Tasks Due to Increased Workload